EMPLOYMENT AGREEMENTEmployment Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • Arizona
EMPLOYMENT AGREEMENT made and entered into as of the 15th day of October,2006, by and between InNexus Biotechnology, Inc.(the "Company"), a Canadian corporation, and Wade F. Brooksby (the "Executive");
SUB-LEASE AGREEMENTSub-Lease Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
THIS SUBLEASE AGREEMENT ("Sub-Lease") is made, entered into and executed this 1 t day of November, 2007, by and between InNexus Biotechnology, Inc. (hereinafter "Sub-Lessor") and Systems Medicine LLC, a wholly owned subsidiary of Cell Therapeutics, Inc. (hereinafter called "Sub-Lessee"). Sub-Lessor and Sub-Lessee contract and agree as follows:
Letter Agreement - Scientific Advisory Board InNexus April 17, 2007Letter Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
As we have discussed, I ask for you to serve as a member of InNexus' Scientific Advisory Board. I am delighted in your interest and below, I have detailed the terms of your service. As a member of the Scientific Advisory Board, I expect you to provide your best advice and recommendations regarding InNexus' antibody technology. providing a peer review function and giving me your best effort in this regard. The Scientific Advisory Board will not be directly responsible for research, publication of research results, participation in research studies, validation of scientific studies, or compilation of data or information. Rather, you serve to advise.
EXHIBIT “B” EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
, 2007 (the “Effective Date”), by and among InNexus Bioscience (Barbados) Inc., a company incorporated in Barbados (“Licensee”) and InNexus Biotechnology International Limited, a company incorporated in Barbados (“Licensor”).
AMENDING AGREEMENTAmending Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
INNEXUS BIOTECHNOLOGY INC., a company having an office located at 13208 East Shea Boulevard, Suite 1135, Scottsdale, Arizona 85259 (the "Company")
SECURITY AGREEMENTConfidential Treatment • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • British Columbia
Innexus Biotechnology Inc., a corporation incorporated under the laws of the Province of British Columbia, Canada having an office at Suite 2760-200 Granville Street, Vancouver, British Columbia
CONSULTING AGREEMENTConsulting Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
INNEXUS BIOTECHNOLOGY, INC, a corporation incorporated under the laws of placeStateBritish Columbia and having an office at addressStreet200 Granville Street, Suite 2760. placeCityVancouver, StateBC, country-regionCanada PostalCodeV6C 1S4
CONSULTING AGREEMENT THIS AGREEMENT dated as at June 8, 2007Consulting Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
INNEXUS BIOTECHNOLOGY INC., having its corporate offices at 200 Granville Street, Suite 2760, Vancouver, BC, Canada V6C 1S4 with principal management being based at 13208 East Shea Boulevard, Suite 200, Scottsdale, AZ 85259 (hereinafter called the "Company")
LETTER OF AGREEMENTLetter of Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • York
Section 2, Fees, The Company shall pay to IRO for its services hereunder a maintenance fee of S 7,250 per month for a: renewable term of 12 months beginning August 1, 2007,
SCIENCE RESEARCH SERVICE AGREEMENTScience Research Service Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • Arizona
Effective June 1, 2007, and continuing until revoked by one of the parties, this Science Research Service Agreement (the “Agreement”) between InNexus Bioscience (Barbados), Inc. (the “Company”) and InNexus Biotechnology Inc. (the “Service Provider”) (collectively, the “Parties”), provides as follows:
ROYALTY AGREEMENTConfidential Treatment • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations
By way of a license agreement dated as of the date hereof (the “License Agreement”), Grantor acquired an irrevocable right and license to Exploit certain Licensed IP from its affiliate, InNexus International, the holder of the underlying Licensed Patents;
LETTER OF AGREEMENT Dated ; July. 24, 2007Letter of Agreement • December 26th, 2007 • Innexus Biotechnology Inc • Pharmaceutical preparations • York
..placeSnsection SnI. Services to be Rendered. The purpose of this letter is to set forth the terms and conditions on which The Investor Relations Croup, Inc. (IRG) agrees to provide InNexus Biotechnology Inc. (the "Company") a comprehensive public relations program, These services may include, but are not limited to: overall management of the public relations program; targeted mailings and phone calls to the media-at-large: assistance with compiling promotional materials; writing and editing news releases and other corporate materials; advice on packaging the Company story: writing pitch letters to and solicitation of the appropriate media and press; syndicated stories; and, daily update reports. For a comprehensive list, see Addendum "A".
